M-Pharma
The computed 12-month bankruptcy probability of M-Pharma is 0.9% (low). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 8 yrs |
| Locations | 1 |
| Publications | 2 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | micro | 22-09-2025 | 2025-00498189 |
| 31-12-2023 | verkort | 26-08-2024 | 2024-00373078 |
| 01-01-2023 | verkort | 22-08-2023 | 2023-00409659 |
| 02-01-2022 | verkort | 08-08-2022 | 2022-20279678 |
| 27-12-2020 | verkort | 20-08-2021 | 2021-52700173 |
| 31-12-2019 | verkort | 21-08-2020 | 2020-44500208 |
| 31-12-2018 | verkort | 29-08-2019 | 2019-56500418 |
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 27-07-2017 |
| Status | Active |
| Postal code | 2600 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11302A0095/00E008 | Flanders | 2.4 ha | 1 · 2,257 m² | 14.7 m |
| 44809I0685/00M003 | Flanders | 147 m² | 1 · 123 m² | 18.6 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
03-01-2025 Wouter Willems appointed as director
- Wouter Willems, Bestuurder
Technical details
{
"events": [
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Wouter Willems",
"address": null,
"birth_date": null,
"profession": "advocaat",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "DUMON, SABLON \u0026 VANHEESWIJCK",
"address": "Verenigingstraat 57-59, 1000 Brussel, Belgi\u00EB",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2024-12-20",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-12-09",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0678.937.543",
"name_full": "M-PHARM\u0410",
"legal_form": "Besloten vennootschap",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Wouter Willems",
"org_rep_person_name": null,
"person_role_at_subject": "Bijzonder gevolmachtigde"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}04-02-2022 Publication in the Belgian Official Gazette, Minor change
Technical details
{
"notary": {
"name": "Frederic HELSEN",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN CVBA",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2022-01-27",
"act_kind_objet": "NEERLEGGING TER GRIFFIE"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2022-01-22",
"unanimous": null
},
"agm_change": {
"new_schedule": null,
"old_schedule": null,
"effective_from_year": null,
"rule_changes_summary": "Wijziging van artikel 18 van de statuten om het boekjaar te laten aanvangen op de dag die onmiddellijk volgt op het einde van het voorgaande boekjaar en te eindigen op de eerstvolgende zondag tussen 26 december en 1 januari."
},
"detected_kind": "fiscal_year_change",
"other_address": null,
"mandate_renewal": null,
"subject_company": {
"kbo": "0678.937.543",
"name_full": "M-Pharma",
"legal_form": "BV"
},
"accounts_deposit": null,
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"een volmacht",
"de geco\u00F6rdineerde tekst van statuten"
],
"fiscal_year_change": {
"new_end_mm_dd": null,
"old_end_mm_dd": null,
"new_start_mm_dd": null,
"old_start_mm_dd": null,
"first_full_new_year": null,
"transition_period_end": "2023-01-01"
},
"liquidation_closure": null,
"officer_designation": null,
"special_procuration": null,
"is_volet_a_only_stub": false,
"vakbekwaamheid_change": null,
"should_reroute_to_category": null,
"single_shareholder_declaration": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | M-Pharma |